FIELD: medicine, infections. SUBSTANCE: composition involves dried spherical form containing immunogen that is able to immunize human or animals and gelatin. Gelatin molecular mass is 80000-120000 Da, gel strength is above 150 (g, 6.2 (3%)). This composition can be used orally for intestines disease prophylaxis. EFFECT: enhanced effectiveness at retained immunogen activity. 6 cl, 10 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| TECHNIQUE OF PRODUCTION OF AN IMMUNOGENIC COMPOSITION FOR ORAL ADMINISTRATION | 0 |
|
SU1836081A3 |
| STABILISED VACCINE COMPOSITION FOR STIMULATION OF IMMUNE RESPONSE AND METHOD FOR ITS OBTAINING | 2003 |
|
RU2339400C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING IBUPROFEN AND DOMPERIDONE FOR MIGRAINE TREATMENT | 1998 |
|
RU2195935C2 |
| ENTEROTOXIN MUTANT EFFECTIVE AS NONTOXIC ORAL STIMULATION AGENT | 1995 |
|
RU2160606C2 |
| SPHINGOID POLYALKYLAMINE CONJUGATES FOR BACTERINATION | 2004 |
|
RU2361577C2 |
| METHOD OF HEPATITIS B TREATMENT | 1992 |
|
RU2104700C1 |
| VACCINES WITH REDUCED FOAM FORMATION | 2015 |
|
RU2731534C2 |
| QUICK-SOLVING DRUG FORM OF ORAL VACCINE IN WHICH STARCH IS USED | 2011 |
|
RU2639447C2 |
| LIVE RECOMBINANT VACCINE OF HEPATITIS B BASED ON SMALLPOX VIRUS FOR ORAL USE AND METHOD OF ITS PREPARING | 1994 |
|
RU2076735C1 |
| METHOD OF INHIBITION OF HEPATITIS B VIRAL INFECTIONS | 1992 |
|
RU2116789C1 |
